HIMS consolidates near $29.56 resistance as weak momentum persists Hims & Hers Health trades at $29.42 today, up 0.51%, as legal risk weighs on outlook and shares remain above…
Hims & Hers CFO Okupe sells $876,846 of HIMS stock Hims & Hers CFO Okupe sells $876,846 of HIMS stock…
Hims & Hers CFO Okupe sells $876,846 of HIMS stock Hims & Hers CFO Okupe sells $876,846 of HIMS stock…
Hims & Hers CFO Okupe sells $876,846 of HIMS stock Hims & Hers CFO Okupe sells $876,846 of HIMS stock…
Hims & Hers CFO Okupe sells $876,846 of HIMS stock Hims & Hers CFO Okupe sells $876,846 of HIMS stock…
Hims And Hers Health (HIMS) Stock Looks Discounted After Its 368% Three Year Run Hims & Hers Health has been a volatile ride, with long term shareholders seeing very large gains while more recent…
Hims & Hers Health (HIMS) Unveils AI Native Weight Loss Care Platform Hims & Hers Health (NYSE:HIMS) introduced an AI native weight loss care platform built around a closed loop clinical system.…
Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately Lead Plaintiff Deadline November 2, 2026...…
Weekly Rundown: Abridge poised for broader VA expansion; Hims & Hers builds out AI-native care Stay up to date on the latest in health tech, digital health and health AI news with this weekly brief.…
Hims & Hers Health (HIMS) Investors with Substantial Losses Have Opportunity to Lead Hims & Hers Class Action Lawsuit /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit…
Revenue Growth Might Change The Case For Investing In Hims & Hers Health Stock (HIMS) Hims & Hers Health reported 38% revenue growth after acquiring Eucalyptus and raised full year guidance, while management flagged weaker…
Hims & Hers Health Inc (HIMS) Stock Up 3.1% and Still Undervalued -- GF Score: 77/100 On September 24, 2026, Hims & Hers Health Inc (HIMS) shares rose 3.1% to a current price of $29.28. The…